Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PF-00217830

Copy Product Info
😃Good
Catalog No. T24613Cas No. 846032-02-8
Alias PF-217830

PF-00217830 is a serotonin 1A receptor agonist, dopamine D2 receptor agonist, and serotonin 2A receptor antagonist.PF-00217830 may be used in the study of schizophrenia.

PF-00217830

PF-00217830

Copy Product Info
😃Good
Purity: 98.72%
Catalog No. T24613Alias PF-217830Cas No. 846032-02-8
PF-00217830 is a serotonin 1A receptor agonist, dopamine D2 receptor agonist, and serotonin 2A receptor antagonist.PF-00217830 may be used in the study of schizophrenia.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$86In StockIn Stock
5 mg$216In StockIn Stock
10 mg$318In StockIn Stock
25 mg$515In StockIn Stock
50 mg$747In StockIn Stock
100 mg$1,050In StockIn Stock
200 mg$1,420-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.72%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

PF-00217830 AI Summary
PF-00217830 exhibits bioactivities related to both dopaminergic and serotonergic systems, showing selectivity for the human D2 receptor over the 5-HT2A receptor. It exhibits moderate to strong inhibition effects and has intrinsic activity at these receptors. The compound demonstrates antipsychotic activity, as evidenced by its ability to reduce catalepsy and inhibit locomotor activity in mice. Furthermore, it functions as an antagonist at the 5-HT2A receptor in rats, with varying levels of inhibition observed at different doses. Pharmacokinetic data indicate favorable oral bioavailability, reasonable clearance, and distribution profiles in both rats and rhesus monkeys, with longer half-lives in the latter..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PF-00217830 is a serotonin 1A receptor agonist, dopamine D2 receptor agonist, and serotonin 2A receptor antagonist.PF-00217830 may be used in the study of schizophrenia.
SynonymsPF-217830
Chemical Properties
Molecular Weight430.54
FormulaC26H30N4O2
Cas No.846032-02-8
SmilesC(CCCOC=1NC=2C(=CC1)CCC(=O)N2)N3CCN(C=4C5=C(C=CC4)C=CC=C5)CC3
Relative Density.1.25 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: < 1 mg/mL (insoluble or slightly soluble)
H2O: < 1 mg/mL (insoluble or slightly soluble)

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF-00217830 | purchase PF-00217830 | PF-00217830 cost | order PF-00217830 | PF-00217830 chemical structure | PF-00217830 formula | PF-00217830 molecular weight